US government health officials have approved the first new drug for Alzheimer's disease in nearly twenty years. Regulators say the drug, which will be known as Aduhelm, is the first treatment that targets the causes of the disease, rather than its symptoms. But the approval is controversial - with some experts saying there's not enough firm evidence of real benefits.
For more news go to: www.dw.com/en/
Follow DW on social media:
Für Videos in deutscher Sprache besuchen Sie: www.youtube.com/dwdeutsch
#Alzheimers #Biogen #FDA